M&A - Aimei Health Technology Co., Ltd.

Form Type: 10-K

Filing Date: 2025-03-28

Corporate Action: Merger

Type: New

Accession Number: 000164117225001169

Filing Summary: Aimei Health Technology Co., Ltd. filed its Form 10-K for the fiscal year ended December 31, 2024. The company is a Cayman Islands exempted company formed as a blank check entity aimed at acquiring businesses, primarily in the biopharmaceutical and medical technology sectors. A significant development in the report is the proposed merger with United Hydrogen Group Inc. through a definitive Business Combination Agreement. The merger includes two sequential mergers: the First Merger with United Hydrogen and the Second Merger where Aimei will become a wholly-owned subsidiary of the newly formed public entity. The agreement outlines conditions for closing, including regulatory approvals, shareholder votes, and financial requirements, indicating a robust structure for the transaction. The report also details the company's IPO which raised $60 million, and the establishment of a trust account for the proceeds, pending the completion of the business combination.

Document Link: View Document